Cardamonin from Alpinia rafflesiana inhibits inflammatory responses in IFN-γ/LPS-stimulated BV2 microglia via NF-κB signalling pathway

International Immunopharmacology

Volumn 12, Issue 4, 2012, Pages 657-665

  Chow, Yuh Lit ^a   Lee, Ka Heng ^a   Vidyadaran, Sharmili ^a   Lajis, Nordin Haji ^a   Akhtar, M Nadeem ^a   Israf, Daud Ahmad ^a   Syahida, Ahmad ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Alpinia rafflesiana; Anti inflammatory; Cardamonin; Microglia; NF B

Indexed keywords

2',4' DIHYDROXY 6' METHOXYCHALCONE; ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; CD14 ANTIGEN; CURCUMIN; CYCLOOXYGENASE 2; DEXAMETHASONE; GAMMA INTERFERON; I KAPPA B; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLANT EXTRACT; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZERUMBONE;

ALPINIA; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; CELL LINE; CELL SURFACE; CONTROLLED STUDY; DNA BINDING; INFLAMMATION; MACROPHAGE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ALPINIA; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD14; CELL LINE; CHALCONES; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; DNA; GENE EXPRESSION; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES;

EID: 84862811331     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.01.009     Document Type: Article

References (32)

1. M.L. Block, and J.S. Hong Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism Prog Neurobiol 76 2005 77 98 (Pubitemid 41242883)
2. B.R. Tambuyzer, P. Ponsaerts, and E.J. Nouwen Microglia: gatekeepers of central nervous system immunology J Leukoc Biol 85 2009 352 370
3. J. Zielasek, and H.P. Hartung Molecular mechanisms of microglial activation Adv Neuroimmunol 6 1996 191 222 (Pubitemid 26279977)
4. Y. Nakamura Regulating factors for microglial activation Biol Pharm Bull 25 2002 945 953 (Pubitemid 39663211)
5. D.A. Israf, T.A. Khaizurin, A. Syahida, N.H. Lajis, and S. Khozirah Cardamonin inhibits COX and iNOS expression via inhibition of p65NF-κB nuclear translocation and Iκ-B phosphorylation in RAW 264.7 macrophage cells Mol Immunol 44 2007 673 679 (Pubitemid 44415023)
6. A. Syahida, D.A. Israf, N.H. Lajis, K. Shaari, H. Mohamed, and A.A. Wahab Cardamonin, inhibits pro-inflammatory mediators in activated RAW 264.7 cells and whole blood Eur J Pharmacol 538 2006 188 194
7. S. Hatziieremia, A.I. Gray, V.A. Ferro, A. Paul, and R. Plevin The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFκB signalling pathways in monocytes/macrophages Br J Pharmacol 149 2006 188 198 (Pubitemid 44360100)
8. R.C. Bheemasankara, R.T. Namosiva, and S. Suryaprakasam Cardamonin and alpinetin from the seeds of Amomum subulatum Planta Med 29 1976 391 392
9. G. Trakoontivakorn, K. Nakahara, H. Shinmoto, M. Takenaka, M. Onishi-Kameyama, and H. Ono Structural analysis of a novel antimutagenic compound, 4-Hydroxypanduratin A, and the antimutagenic activity of flavonoids in a Thai spice, fingerroot (Boesenbergia pandurata Schult.) against mutagenic heterocyclic amines J Agric Food Chem 49 2001 3046 3050 (Pubitemid 32826108)
10. Z.T. Wang, C.W. Lau, F.L. Chan, X. Yao, Z.Y. Chen, and Z.D. He Vasorelaxant effects of cardamonin and alpinetin from Alpinia henryi K. Schum J Cardiovasc Pharmacol 37 2001 596 606 (Pubitemid 32377915)
11. Y.M. Lin, Y.S. Zhou, M.T. Flavin, L.M. Zhou, W.G. Niea, and F.C. Chen Chalcones and flavonoids as anti-tuberculosis agents Bioorg Med Chem 10 2002 2795 2802 (Pubitemid 34626243)
12. I. Jantan, S.M. Raweh, H.M. Sirat, S. Jamil, Y.H. Mohd Yasin, and J. Jalil Inhibitory effect of compounds from Zingiberaceae species on human platelet aggregation Phytomedicine 15 2008 306 309
13. H. Mohamad, F. Abas, D. Permana, N.H. Lajis, A.M. Ali, and M.A. Sukari DPPH free radical scavenger components from the fruits of Alpinia rafflesiana Wall. ex. Bak. (Zingiberaceae) Z Naturforsch C 59 2004 811 815 (Pubitemid 40059820)
14. R. Nagasaka, C. Chotimarkorn, I.M. Shafiqul, M. Hori, H. Ozaki, and H. Ushio Anti-inflammatory effects of hydroxycinnamic acid derivatives Biochem Biophys Res Commun 358 2007 615 619 (Pubitemid 46755749)
15. 2 promotes interleukin-6 biosynthesis mediated by an activation of cyclic AMP-response element-binding protein in 1321N1 human astrocytoma cells Mol Pharmacol 68 2005 670 679 (Pubitemid 41206020)
16. A. Takahashi, N. Yamamoto, and A. Murakami Cardamonin suppresses nitric oxide production via blocking the IFN-γ/STAT pathway in endotoxin-challenged peritoneal macrophages of ICR mice Life Sci 89 2011 337 342
17. M. Combrinck, J. Williams, M.A.D. Berardinis, D. Warden, M. Puopolo, and A.D. Smith Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease J Neurol Neurosurg Psychiatry 77 2006 85 88 (Pubitemid 43022699)
18. K. Rejdak, M.J. Eikelenboom, A. Petzold, E.J. Thompson, Z. Stelmasiak, and R.H. Lazeron CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis Neurology 63 2004 1439 1445 (Pubitemid 39426278)
19. T.J. Montine, K.R. Sidell, B.C. Crews, W.R. Markesbery, L.J. Marnett, and L.J. Roberts Elevated CSF prostaglandin E2 levels in patients with probable AD Neurology 53 1999 1495 1498 (Pubitemid 29491943)
20. M.T. Heneka, M.K. O'Banion, D. Terwel, and M.P. Kummer Neuroinflammatory process in Alzheimer's disease J Neural Transm 117 2010 919 947
21. M.K. McCoy, T.N. Martinez, K.A. Ruhn, D.E. Szymkowski, C.G. Smith, and B.R. Botterman Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease J Neurosci 26 2006 9365 9375 (Pubitemid 44396849)
22. Y.J. Kim, H. Ko, J.S. Park, I.H. Han, E.C. Amor, and J.W. Lee Dimethyl cardamonin inhibits lipopolysaccharide-induced inflammatory factors through blocking NF-κB p65 activation Int Immunopharmacol 10 2010 1127 1134
23. Y.H. Kim, J.S. Kim, H. Park, and H.P. Kim Anti-inflammatory activity of the synthetic chalcone derivatives: inhibition of inducible nitric oxide synthase-catalyzed nitric oxide production from lipopolysaccharide-treated RAW 264.7 cells Biol Pharm Bull 30 2007 1450 1455 (Pubitemid 47282192)
24. S.J. Won, C.T. Liu, L.T. Tsao, J.R. Weng, H.H. Ko, and J.P. Wang Synthetic chalcones as potential anti-inflammatory and cancer chemopreventive agents Eur J Med Chem 40 2005 103 112
25. H.H. Ko, L.T. Tsao, K.L. Yu, C.T. Liu, J.P. Wang, and C.N. Lin Structure-activity relationship studies on chalcone derivatives: the potent inhibition of chemical mediators release Bioorg Med Chem 11 2003 105 111
26. D.L. Laskin, and K.J. Pendino Macrophages and inflammatory mediators in tissue injury Annu Rev Pharmacol Toxicol 35 1995 655 677
27. J.R. Bethea, I.Y. Chung, S.M. Sparacio, G.Y. Gillespie, and E.N. Benveniste Interleukin-1/3 induction of tumor necrosis factor-alpha gene expression in human astroglioma cells J Neuroinflammation 36 1992 179 191
28. D. Heumann, and T. Roger Initial responses to endotoxins and Gram-negative bacteria Clin Chim Acta 323 2002 59 72 (Pubitemid 34804795)
29. E.G. Reed-Geaghan, J.C. Savage, A.G. Hise, and G.E. Landreth CD14 and toll-like receptors 2 and 4 are required for fibrillar Aβ-stimulated microglial activation J Neurosci 29 2009 11982 11992
30. M. Boncler, B. Luzak, M. Rozalski, J. Golanski, B. Rychlik, and C. Watala Acetylsalicylic acid is compounding to antiplatelet effect of C-reactive protein Thromb Res 119 2007 209 216 (Pubitemid 44765069)
31. K. Takeda, and S. Akira TLR signaling pathways Semin Immunol 16 2004 3 9 (Pubitemid 38147427)
32. Y. Liu, S. Walter, M. Stagi, D. Cherny, M. Letiembre, and W. Schulz-Schaeffer LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide Brain 128 2005 1778 1789 (Pubitemid 41373649)